Cleared Traditional

K201256 - Procise CRP, ProciseDx Analyzer, ProciseDx Calibration Cartridge (FDA 510(k) Clearance)

Nov 2022
Decision
907d
Days
Class 2
Risk

K201256 is an FDA 510(k) clearance for the Procise CRP, ProciseDx Analyzer, ProciseDx Calibration Cartridge. This device is classified as a C-reactive Protein, Antigen, Antiserum, And Control (Class II - Special Controls, product code DCK).

Submitted by Procise Diagnostics (San Diego, US). The FDA issued a Cleared decision on November 4, 2022, 907 days after receiving the submission on May 11, 2020.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5270.

Submission Details

510(k) Number K201256 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 11, 2020
Decision Date November 04, 2022
Days to Decision 907 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code DCK - C-reactive Protein, Antigen, Antiserum, And Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5270